Post-ERCP Complications: Immediate Assessment and Management
This patient requires urgent evaluation for post-ERCP cholangitis or stent occlusion, with immediate blood cultures, repeat liver function tests, and empiric broad-spectrum antibiotics if infection is suspected.
Initial Diagnostic Approach
Your patient's constellation of symptoms—elevated LFTs, jaundice, anorexia, and weakness after biliary stent placement—suggests either:
- Stent occlusion with cholangitis (most concerning)
- Post-ERCP pancreatitis
- Benign transient enzyme elevation
Key Clinical Discriminators to Assess Immediately:
- Fever or rigors: Suggests cholangitis requiring urgent intervention
- Severity of abdominal pain: Severe epigastric pain radiating to back suggests pancreatitis
- Timing: Symptoms within 24-48 hours vs. weeks/months post-procedure
- Degree of LFT elevation: Transient mild elevations are common and benign 1
Management Algorithm
If Fever/Sepsis Present (Acute Cholangitis):
Start empiric IV antibiotics immediately and arrange urgent repeat ERCP for stent evaluation/exchange 2. Cholangitis from stent occlusion can occur even months after placement—plastic stents typically clog within 3-5 months 3. The guideline recommendation is clear: when biliary sepsis or acute cholangitis is suspected with dilated ducts, endoscopic internal biliary catheter placement or exchange is the appropriate therapeutic procedure 2.
If No Fever But Progressive Jaundice:
Obtain urgent imaging (ultrasound or CT) to assess for:
- Biliary dilation proximal to stent
- Stent position/migration
- Fluid collections
If stent occlusion confirmed: Arrange semi-urgent ERCP for stent exchange 3
If Minimal Symptoms with Isolated LFT Elevation:
This scenario is actually common and often benign. Transient post-ERCP liver test elevations occur in approximately 43% of patients due to papillary trauma and transient biliary pressure elevation 1. In the absence of significant clinical signs or symptoms, these isolated laboratory abnormalities should be managed expectantly 1.
However, given your patient has jaundice and constitutional symptoms (anorexia, weakness), this is NOT an isolated asymptomatic LFT elevation—proceed with workup as above.
Critical Pitfalls to Avoid
Do not assume benign transient elevation when jaundice and systemic symptoms are present. While the research shows that asymptomatic post-ERCP LFT elevations are common and self-limited 1, your patient is symptomatic. The combination of jaundice + anorexia + weakness demands investigation for stent dysfunction or infection.
Do not delay antibiotics if cholangitis is suspected. The 2019 ACR guidelines emphasize that patients with suspected biliary sepsis or acute cholangitis require urgent drainage 2. The 2023 ASGE guideline specifically recommends administering antibiotics during ERCP when biliary drainage cannot be ensured 4.
Remember that plastic stents have limited patency. If this was a temporary plastic stent placed for stone disease, it should typically be exchanged every 3 months to prevent cholangitis from clogging 3, 5. Failure to adhere to scheduled stent exchanges results in complications in 70% of cases 5.
Specific Laboratory Monitoring
Repeat the following urgently:
- Complete blood count (looking for leukocytosis)
- Comprehensive metabolic panel with LFTs
- Lipase (to evaluate for post-ERCP pancreatitis)
- Blood cultures if febrile
- INR/PT (coagulopathy from biliary obstruction) 6
The pattern of LFT elevation helps differentiate: predominantly elevated alkaline phosphatase and bilirubin suggest cholestatic obstruction, while transaminase elevation >1000 suggests hepatocellular injury or ischemia 7.